110 / 464
SUNDAY 7 MAY 2017
110
SCIENTIFIC PROGRAMME
| Programme and Exhibition Guide
A. Gulyban (Belgium), P. Berkovic, F. Lakosi, J. Hermesse, P.A. Coucke,
V. Baart, D. Dechambre
OC-0263
10:40 > Assessment of Atlas based auto-segmentation in Breast Contouring
P.H. Fok (Hong Kong SAR China), W.K. Fung, C.H.P. Ho, G. Chiu
OC-0264
10:50 > Evaluating variability of contouring using ESTRO guidelines for elective
breast cancer radiotherapy
D. Megias (UK), M. Sydenham, D. Wheatley, M. Maclennan,
E. Spezi, A.M. Brunt
OC-0265
11:00 > Motion specific target delineation significantly reduce treated volumes
in liver SBRT
J. Wielaard (The Netherlands), C.H. Slump, K. Muller, A.W.H. Minken,
H. Westendorp
OC-0266
11:10 > Automatic contour propagation of breast and heart for re-planning in
breast cancer radiotherapy
G.G. Sikkes (The Netherlands), L.T.C. Meijers, A.N.T.J. Kotte,
I.E. Van Dam, B. Van Asselen, H.J.G.D. Van den Bongard
OC-0267
11:20 > Volumetric comparison between PET/CT and CT simulation for target
delineation in esophageal cancer
E. Jimenez-Jimenez (Spain), P. Mateos, N. Aymar, I. Ortiz, R. Roncero,
M. Vidal, M. Gimenez, F. Romero, S. Sabater
OC-0268
MULTIDISCIPLINARY TUMOUR BOARD
Lymphoma
10:30 - 11:30 | LEHAR 4
Chair: L. Specht (Denmark)
ESTRO Fellow: B. De Bari (France)
Panellist: M. Mayerhöfer (Austria)
Panellist: U. Jäger (Austria)
Panellist: I. Simonitsch-Klupp (Austria)
PROFFERED PAPERS
Prostate 2
10:30 - 11:30 | STOLZ 1-2
Chair: R. Alonzi (UK)
Chair: H. Westerveld (The Netherlands)
10:30 > Single Dose Compared to Fractionated High-Dose Rate Brachytherapy
for Localised Prostate Cancer
P. Hoskin (UK), A. Rojas, P. Ostler, R. Hughes, R. Alonzi, G. Lowe
OC-0269
10:40 > QoL and toxicity of HDR prostate brachytherapy as monotherapy 19Gy
single fraction:phase II trial